Clinical Trials Browser

OTHER × Nasopharyngeal Neoplasms × Capecitabine × Clear all

NCT05807880 2026-01-23

ALTER-HN005

Phase 2 Active not recruiting

Nasopharyngeal Neoplasms

NCT02360501 2016-04-20

Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma

Phase 2 Completed

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms